LONIAL SAGAR sold 19.8% of their position (25.93K shares) of TG THERAPEUTICS, INC. on the open market
Open‑market sale worth $432.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/20/2024ACC: 0001437749-24-020851
-3.68K
Net shares
Net seller
$432.9K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
22.25K acquired · 25.93K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−9.59K
Price / share
$16.39
Trade value
$157.10K
% of position
8.8%
6/17/2024
108.88K→99.29K
Common Stock
Direct
Shares
+22.25K
Price / share
—
Trade value
—
% of position
22.4%
6/19/2024
99.29K→121.54K
Common Stock
Direct
Shares
−16.35K
Price / share
$16.87
Trade value
$275.79K
% of position
13.5%
6/20/2024
121.54K→105.19K
Total
Net shares
−3.68K
Net value
-$432.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/17/2024 | S · Sale | −9.59K | $16.39 | $157.10K | 8.8% | 108.88K | 99.29K |
| Common Stock Direct | 6/19/2024 | A · Award | +22.25K | — | — | 22.4% | 99.29K | 121.54K |
| Common Stock Direct | 6/20/2024 | S · Sale | −16.35K | $16.87 | $275.79K | 13.5% | 121.54K | 105.19K |
| Total | −3.68K | -$432.89K | ||||||
Derivative Transactions0
No derivative transactions reported